At this time, the significance of SGLT2 expression in tumors is not known, but at a minimum, Me4FDG PET offers significant advantages over conventional 2FDG PET in imaging advanced glioblastomas (see Fig. 5). The gene discussed is SLC5A2; the disease is glioblastoma.